CompletedPhase 3NCT03065244
KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)
Studying Kawasaki disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, San Diego
- Principal Investigator
- Jane C Burns, MDUCSD
- Intervention
- IVIG(drug)
- Enrollment
- 105 target
- Eligibility
- 17 years · All sexes
- Timeline
- 2017 – 2020
Study locations (29)
- UAB Children's of Alabama, Birmingham, Alabama, United States
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- University of California San Diego, La Jolla, California, United States
- Memorial Care, Long Beach, California, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- David Geffen School of Medicine at UCLA, Los Angeles, California, United States
- Harbor-UCLA Medical Center, Los Angeles, California, United States
- UCSF Benioff Children's Hospital-Oakland, Oakland, California, United States
- Children's Hospital of Orange County, Orange, California, United States
- UCSF Benioff Children's Hospital-San Francisco, San Francisco, California, United States
- Cedar-Sinai Medical Center, West Hollywood, California, United States
- Children's Hospital of Colorado, Aurora, Colorado, United States
- Children's National Health SYstem, Washington D.C., District of Columbia, United States
- Children's Healthcare of Atlanta, Atlanta, Georgia, United States
- Comer Children's Hospital, Chicago, Illinois, United States
- +14 more locations on ClinicalTrials.gov
Collaborators
Patient-Centered Outcomes Research Institute
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03065244 on ClinicalTrials.govOther trials for Kawasaki disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT05643651Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki DiseaseChildren's Hospital of Fudan University
- RECRUITINGNANCT07291245Kawasaki MATCH TrialUniversity of California, San Diego
- ENROLLING BY INVITATIONNCT06641843Magnetic Resonance Myocardial Stress Perfusion in Pediatric Patients with Cardiovascular DiseaseWest China Second University Hospital
- RECRUITINGPHASE4NCT06978439Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki DiseaseChildren's Hospital of Fudan University
- RECRUITINGPHASE3NCT04656184A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG TreatmentAssistance Publique - Hôpitaux de Paris
- ENROLLING BY INVITATIONNCT06641817The Value of Cardiovascular Imaging in Kawasaki DiseaseWest China Second University Hospital
- RECRUITINGNCT06993636Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 YearsChildren's Hospital of Fudan University
- RECRUITINGNCT06305611European and North Indian Cohort of KaWasaki dIseaseMeyer Children's Hospital IRCCS